Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3043525	li-hsvab	— (—)	558	636	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of the central nervous system

33.75

144.16

1.3

1.1

—

Viral infections of the central nervous system

31.60

132.06

1.3

1.2

—

Convulsions, not elsewhere classified

16.56

100.62

1.2

—

Epilepsy

107

109

9.85

92.98

1.2

1.1

—

Focal epilepsy

9.60

69.13

1.2

1.1

—

Other symptoms and signs involving cognitive functions and awareness

115

168

6.45

68.48

1.2

1.1

—

Headache

128

179

5.99

67.83

1.1

—

Neurological diseases

144

107

6.79

66.36

1.2

1.1

—

Meningitis

26.15

66.16

1.3

1.2

—

Focal epilepsy, strict definition

9.58

65.62

1.2

1.1

—

General symptoms and signs

192

212

4.55

61.24

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

9.30

60.04

1.2

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

179

330

3.81

52.90

1.2

1.1

—

Fever of other and unknown origin

166

5.54

50.58

1.2

1.1

—

Certain infectious and parasitic diseases

154

175

4.41

47.67

1.2

1.1

—

Viral encephalitis, not elsewhere classified/unspecified

63.33

45.99

1.4

1.2

—

Other encephalitis

76.46

45.41

1.4

1.1

—

Encephalitis

60.59

44.76

1.3

1.2

—

Malaise and fatigue

134

5.49

42.78

1.1

—

Intracranial trauma

6.92

42.70

1.1

—

Cerebrovascular diseases

138

254

3.90

42.55

1.2

1.1

—

Sequelae of cerebrovascular disease

122

5.56

38.72

1.2

1.1

—

Bacterial infection, other or unspecified

104

226

4.16

37.72

1.2

1.1

—

Viral meningitis

26.46

37.35

1.5

1.3

—

Neurological diseases, wide definition

14.03

37.00

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

6.52

36.52

1.1

1.2

—

Abnormal findings on diagnostic imaging of central nervous system

16.95

35.88

1.3

—

Implicit Sepsis

128

287

3.47

34.54

1.2

1.1

—

Anaemias

8.67

33.57

1.2

1.0

—

Speech disturbances, not elsewhere classified

10.38

33.35

1.2

—

Concussion

6.42

32.89

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

137

307

3.25

32.71

1.2

1.1

—

Continuous positive airway pressure

7.45

32.13

1.2

1.1

—

Episodal and paroxysmal disorders

161

267

3.09

31.69

1.2

1.1

—

Stroke, excluding SAH

109

221

3.67

31.47

1.2

1.1

—

Stroke, including SAH

112

232

3.58

31.16

1.2

1.1

—

Spirochaetal infections, other/unspecified

9.55

29.74

1.1

1.2

—

Medical observation and evaluation for suspected diseases and conditions

111

149

3.82

29.46

1.1

—

Other bacterial diseases

145

341

2.94

29.11

1.1

—

Status epilepticus

41.04

29.07

1.2

—

Cerebrovascular diseases (FINNGEN)

101

4.97

28.98

1.1

—

Implicit bacterial Sepsis

161

4.28

28.48

1.1

—

Other degenerative diseases of the nervous system

8.42

27.84

1.1

—

Bacterial Sepsis

182

3.97

27.60

1.1

—

Infections, IBD-co-morbidities

17.04

27.44

1.1

1.2

—

Visual disturbances and blindness

245

3.60

27.01

1.2

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

8.96

26.77

1.3

—

Other spirochaetal diseases

115

4.98

26.68

1.1

1.2

—

STROKE

195

3.53

26.50

1.2

1.1

—

Lyme disease

113

4.98

26.21

1.1

1.2

—

Other and unspecified polyneuropathies, also in other diseases

5.83

26.12

1.1

1.2

—

Implicit viral Sepsis

6.14

25.76

1.3

1.1

—

Viral Sepsis

6.14

25.76

1.3

1.1

—

Ischaemic Stroke, excluding all haemorrhages

215

3.38

24.83

1.2

1.1

—

GASTRO-related operations

111

171

3.26

23.63

1.2

1.1

—

Any gastric operation

111

171

3.26

23.63

1.2

1.1

—

Other neurological diseases

111

306

2.92

23.06

1.2

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

154

347

2.51

21.83

1.1

—

Dizziness and giddiness

267

3.01

21.79

1.1

—

Influenza and pneumonia

146

386

2.49

21.28

1.1

—

Migraine

151

3.78

21.18

1.2

1.1

—

Paralytic strabismus

9.34

20.87

1.1

1.2

—

Pneumonia, organism unspecified

128

358

2.59

20.72

1.2

1.1

—

ILD medications: immunosuppressive drugs

293

2.95

19.95

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

301

2.93

19.43

1.1

—

ILD medications

152

352

2.37

19.09

1.1

—

Visual disturbances

228

3.21

18.86

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

132

396

2.39

18.17

1.2

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

121

301

2.52

17.95

1.2

1.1

—

121

301

2.52

17.95

1.2

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

132

392

2.37

17.71

1.1

—

Hydrocephalus

8.27

17.51

1.1

1.3

—

Pneumonitis due to solids and liquids

8.51

17.13

1.2

—

Organic, including symptomatic, mental disorders

175

3.10

16.84

1.2

—

Viral infections characterized by skin and mucous membrane lesions

208

3.18

16.83

1.3

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

136

3.70

16.58

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.26

16.57

1.3

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

131

394

2.31

16.54

1.1

—

Cerebral palsy and other paralytic syndromes

6.12

16.37

1.3

1.2

—

Diseases of the myoneural junction and muscle

5.69

16.31

1.2

—

All pneumoniae

131

395

2.29

16.30

1.1

—

Traumatic subdural haemorrhage

10.44

16.11

1.1

1.0

—

Zoster [herpes zoster]

4.95

15.90

1.3

1.1

—

Visual impairment including blindness (binocular or monocular)

8.39

15.38

1.3

1.2

—

Explicit Sepsis

185

3.17

15.36

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

149

2.93

15.30

1.2

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

321

2.57

15.23

1.2

1.1

—

Nausea and vomiting

107

3.96

15.21

1.1

—

Injuries to the head

138

416

2.16

14.82

1.1

—

Symptoms and signs involving the urinary system

105

340

2.39

14.80

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

149

2.86

14.75

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases

134

335

2.22

14.72

1.1

1.2

—

Symptoms and signs involving speech and voice

154

3.38

14.72

1.2

1.1

—

First line medication for Crohn's disease

138

345

2.18

14.49

1.1

—

Syncope and collapse

131

3.45

14.45

1.2

1.1

—

Oral corticosteroids

136

381

2.16

14.34

1.1

—

Inflammatory bowel disease treatment related agents

145

389

2.12

14.33

1.1

—

Follow-up care involving plastic surgery

12.84

14.27

1.1

1.5

—

Hypo-osmolality and hyponatraemia

4.84

14.17

1.1

1.2

—

Disorders of thyroid, IBD co-morbidities

10.95

14.15

1.2

1.3

—

Renal tubulo-interstitial diseases

110

369

2.29

14.06

1.1

—

Hard cardiovascular diseases

100

265

2.42

13.90

1.2

1.1

—

Herpesviral [herpes simplex] infections

5.22

13.41

1.3

1.1

—

Systemic connective tissue disorders

164

3.18

13.35

1.1

—

Bacterial meningitis

21.40

13.35

1.1

—

Other antidepressants

130

313

2.17

13.31

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

127

329

2.15

13.02

1.1

1.2

—

Septicaemia

180

3.00

12.92

1.1

—

Autoimmune diseases related-to ILD

107

430

2.19

12.76

1.1

1.2

—

Iron deficiency anaemia

204

2.87

12.69

1.1

—

Other demyelinating diseases of the central nervous system

11.92

12.64

1.1

1.5

—

Other and unspecified myopathies

5.98

12.58

1.2

—

Fall on same level

141

390

2.02

12.36

1.1

—

Persons encountering health services in other circumstances

194

2.89

12.25

1.2

1.1

—

Oedema, not elsewhere classified

3.87

12.12

1.2

—

Acute tubulo-interstitial nephritis

309

2.39

12.10

1.2

1.1

—

Tramadol

100

284

2.27

12.06

1.1

1.2

—

Other septicaemia

161

3.05

11.99

1.1

—

Other headache syndromes

156

3.08

11.76

1.2

1.1

—

Diplopia

4.75

11.64

1.1

1.2

—

Other and unspecified iron deficiency

142

3.17

11.58

1.1

—

Strabismus

122

3.36

11.56

1.2

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

207

2.76

11.47

1.1

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

7.12

11.41

1.1

1.3

—

Intracranial injury

286

2.44

11.21

1.1

—

Cardiovascular diseases

160

2.56

11.16

1.2

1.1

—

Diseases of the eye and adnexa

216

2.27

11.15

1.1

1.2

—

Sixth [abducent] nerve palsy

11.01

11.07

1.1

1.4

—

Other disorders of urethra and urinary system

273

2.31

11.01

1.2

1.1

—

Other diseases of urinary system

122

339

2.03

10.85

1.2

1.1

—

Parkinson's disease, strict definition, excluding more controls

8.60

10.85

1.1

1.0

—

Used for control exclusion in common control thyroid runs

123

306

2.04

10.82

1.1

—

Nerve, nerve root and plexus disorders

127

405

1.97

10.78

1.2

1.1

—

All influenza

3.62

10.75

1.1

—

L04AX Other immunosuppressants

297

2.39

10.74

1.1

—

Second line medication for Crohn's disease

304

2.37

10.67

1.1

—

Parkinson's disease, excluding more controls

7.71

10.66

1.1

1.0

—

Glomerular disorders in diseases classified elsewhere

5.02

10.51

1.1

1.3

—

Exclusions for E4_PCOS_BROAD

3.98

10.45

1.3

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

111

3.34

10.36

1.1

—

Lung diseases due to external agents

4.54

10.22

1.2

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

7.83

10.15

1.1

1.3

—

Other necrotizing vasculopathies (FG)

7.18

10.13

1.1

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

191

2.36

10.09

1.1

—

Psychiatric diseases

124

314

1.98

10.07

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

109

2.95

10.02

1.0

1.1

—

Nutritional anaemias

239

2.49

9.99

1.1

—

Other systemic involvement of connective tissue (FG)

103

3.38

9.99

1.1

1.2

—

Benzodiazepine use

117

429

1.94

9.84

1.1

—

Enlarged lymph nodes

5.14

9.82

1.1

1.2

—

Cerebral cysts

6.86

9.73

1.1

1.3

—

COPD/asthma related infections

119

301

1.98

9.71

1.2

1.1

—

COPD/asthma/ILD related infections

119

301

1.98

9.71

1.2

1.1

—

Sleep disorders (combined)

114

381

1.96

9.70

1.1

—

Bleeding

353

2.04

9.62

1.1

1.2

—

Oxycodone

191

2.64

9.60

1.1

1.2

—

Parasetamol

216

2.18

9.58

1.1

—

Dorsalgia

118

327

1.96

9.51

1.1

—

Bell's palsy

4.36

9.32

1.1

1.2

—

Complications of surgical and medical care, not elsewhere classified

112

418

1.92

9.20

1.1

—

Examination and observation for other reasons

148

2.51

9.12

1.2

1.1

—

Abnormalities of gait and mobility

4.28

9.11

1.0

1.2

—

Fitting and adjustment of other devices

172

2.65

9.11

1.0

1.2

—

Persons encountering health services for examination and investigation

149

2.39

9.09

1.1

—

Intestinal infectious diseases

107

431

1.93

9.09

1.1

—

Depression medications

3.87

9.08

1.2

1.0

—

Moderate visual impairment, binocular

18.76

8.94

1.2

1.4

—

Migraine with aura

3.54

8.92

1.2

1.1

—

Vitamin deficiency, wide

8.05

8.86

1.1

1.3

—

Vitamin deficiency

8.05

8.86

1.1

1.3

—

Complications of medical and surgical care

389

2.05

8.75

1.2

1.1

—

Opioids

113

308

1.93

8.71

1.1

—

Other dorsopathies, not elsewhere classified

118

329

1.89

8.65

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

6.03

8.65

1.1

1.2

—

Other pulmonary diagnosis

205

2.13

8.59

1.2

1.1

—

Autoimmune diseases

123

337

1.87

8.56

1.1

1.2

—

Malignant neoplasm of brain

8.53

8.47

1.1

1.5

—

Other systemic involvement of connective tissue

126

2.94

8.47

1.1

1.2

—

Malignant neoplasm of eye, brain and central nervous system

7.55

8.42

1.1

1.4

—

Unspecified urinary incontinence

5.17

8.40

1.2

—

Falls/tendency to fall

124

336

1.85

8.38

1.1

1.2

—

Demyelinating diseases of the central nervous system

4.65

8.34

1.1

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

5.80

8.33

1.2

1.3

—

Cervicalgia

3.30

8.32

1.1

1.2

—

ILD medications: azathioprine

3.98

8.32

1.1

1.2

—

Diagnoses used for exclusion with ILD

117

3.00

8.28

1.2

1.1

—

Secondary hypertension

5.73

8.22

1.1

—

Glomerular diseases

3.42

8.20

1.1

1.2

—

COPD differential diagnosis

206

2.09

8.18

1.2

1.1

—

Sensorineural hearing loss

298

2.02

8.14

1.1

1.2

—

Impacted cerumen

4.54

8.11

1.1

1.2

—

Nontraumatic intracranial haemmorrhage

3.57

8.10

1.0

1.1

—

Somnolence, stupor and coma

9.14

8.09

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

346

2.05

8.08

1.1

—

Normal-pressure hydrocephalus

6.54

8.07

1.1

1.3

—

Other specific joint derangements/joint disorders

281

2.03

8.06

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.76

8.05

1.2

1.1

—

Pain in joint

199

2.23

8.02

1.2

—

Other soft tissue disorders, not elsewhere classified

103

336

1.89

7.92

1.1

—

Conductive and sensorineural hearing loss

317

1.97

7.91

1.1

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

235

2.32

7.89

1.2

—

ILD differential diagnosis

206

2.07

7.87

1.2

1.1

—

Insulin medication

294

2.10

7.83

1.2

1.1

—

Polyarthropathies

251

2.07

7.82

1.1

—

Other disorders of lacrimal gland

172

2.56

7.80

1.2

1.1

—

MS-disease / Multiple Sclerosis

5.38

7.72

1.0

1.2

—

Disorders of optic nerve and visual pathways

4.33

7.67

1.2

—

Excluding asthma or asthma-COPD overlap

205

2.05

7.65

1.2

1.1

—

Azathioprine

3.72

7.61

1.1

1.2

—

Hemiplegia

6.70

7.60

1.1

1.3

—

Anxiety disorders, excluding more controls

294

1.96

7.55

1.1

—

Exposure to other specified factors

394

1.95

7.51

1.2

1.1

—

Low back pain

318

1.96

7.27

1.2

—

Dysphagia

110

2.91

7.25

1.1

—

Pain, not elsewhere classified

3.48

7.25

1.3

1.1

—

Abnormalities of heart beat

183

2.44

7.22

1.2

1.1

—

Diseases of pulp and periapical tissues

185

2.44

7.21

1.1

1.2

—

Other necrotizing vasculopathies

5.02

7.18

1.1

1.3

—

Third [oculomotor] nerve palsy

20.29

7.15

1.1

1.4

—

Insulin, intermediate and long-acting

307

2.08

7.14

1.2

1.1

—

Other symptoms and signs involving general sensations and perceptions

20.12

7.13

1.0

1.6

—

Other reaction to severe stress, and adjustment disorders

174

2.47

7.13

1.2

1.1

—

Migraine without aura

3.54

7.13

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

332

2.00

7.06

1.2

1.1

—

Sleep apnoea

100

372

1.82

7.04

1.2

1.1

—

Chronic periapical parodontitis

3.03

7.02

1.1

1.2

—

Type 1 diabetes

112

2.86

7.01

1.1

—

Complications of procedures, not elsewhere classified

401

1.88

7.00

1.1

—

Disorders of speech understanding and production

6.78

6.98

1.4

1.3

—

Finngen Rheumatological endpoints

105

331

1.81

6.94

1.1

—

Metabolic disorders

101

345

1.82

6.93

1.2

1.1

—

Antihypertensive medication - note that there are other indications

172

2.13

6.92

1.2

1.1

—

Disorders of lacrimal system

214

2.29

6.88

1.2

1.1

—

Cystitis

292

1.89

6.87

1.2

1.1

—

Presence of other devices

3.05

6.86

1.1

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

142

2.61

6.85

1.1

—

Type 2 diabetes, wide definition

295

1.90

6.83

1.1

1.2

—

Codeine

101

304

1.83

6.83

1.1

—

Intracerebral haemorrhage

4.10

6.80

1.0

1.2

—

Cellulitis

104

2.89

6.72

1.2

—

Visual field defects

4.46

6.70

1.1

1.2

—

Disorders of other endocrine glands

213

2.27

6.69

1.2

1.1

—

Dementia

137

2.37

6.59

1.1

—

Infections of the skin and subcutaneous tissue

318

2.01

6.44

1.1

—

Dementia, including avohilmo

152

2.27

6.39

1.1

1.2

—

Symptoms and signs involving the digestive system and abdomen

109

311

1.76

6.38

1.1

—

Neurotic, stress-related and somatoform disorders

358

1.81

6.34

1.1

—

Aplastic and other anaemias

216

2.20

6.32

1.1

—

Other viral diseases

142

2.53

6.29

1.2

1.1

—

Sleep apnoea, including avohilmo

103

383

1.75

6.28

1.2

1.1

—

Endocrine, nutritional and metabolic diseases

230

1.88

6.20

1.2

1.1

—

Polycystic ovarian syndrome, consortium definition

213

1.98

6.20

1.2

1.1

—

Other and unspecified anaemias

198

2.25

6.19

1.1

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

3.96

6.16

1.3

1.2

—

Any mental disorder

115

337

1.71

6.15

1.1

—

Exposure to unspecified factor

101

454

1.73

6.14

1.1

—

Mycoses

121

2.65

6.13

1.1

1.2

—

Insulin, fast-acting

181

2.32

6.11

1.2

1.1

—

Chronic kidney disease

138

2.53

6.11

1.1

1.2

—

Dermatitis due to substances taken internally

5.81

6.11

1.3

1.4

—

Other anaemias

199

2.23

6.08

1.1

1.2

—

L04AA Selective immunosuppressants

2.83

6.08

1.2

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

280

2.03

6.04

1.1

—

External causes of morbidity and mortality

186

1.97

6.04

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

382

1.74

6.03

1.2

1.1

—

Other disorders of ear

365

1.75

5.99

1.1

—

Alcohol withdrawal state with delirium

4.53

5.98

1.3

1.2

—

Pure hypercholesterolaemia

276

1.87

5.94

1.2

1.1

—

Mood disorders, excluding more controls

328

1.76

5.93

1.1

—

Dentinal caries

100

2.79

5.91

1.1

1.2

—

Type 1 diabetes, wide definition, subgroup 1

2.84

5.91

1.1

—

Anxiety disorders

366

1.76

5.87

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.29

5.85

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

307

1.86

5.84

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

107

2.72

5.83

1.1

1.2

—

Benign neoplasm of meninges

4.18

5.82

1.1

1.2

—

Provisional assignment of new diseases of uncertain etiology

224

2.14

5.81

1.2

1.1

—

Codes for special purposes

224

2.14

5.81

1.2

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

345

1.91

5.80

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

167

2.34

5.79

1.3

1.1

—

Insulin, fast-acting or short human

192

2.24

5.79

1.2

—

Other female pelvic inflammatory diseases

3.07

5.75

1.3

1.1

—

Postprocedural disorders of nervous system

5.02

5.74

1.1

1.3

—

Speech and linguistic disorders, excluding more controls

5.47

5.64

1.4

1.3

—

Diseases of the respiratory system

170

1.98

5.63

1.2

1.1

—

Acute generalized exanthematous pustulosis

5.91

5.63

1.3

1.4

—

Depression or dysthymia

200

1.93

5.61

1.1

—

Other CVD (FINNGEN)

4.07

5.60

1.1

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

13.03

5.59

1.1

1.7

—

Brain glioblastoma and astrocytoma

13.03

5.59

1.1

1.7

—

Pulmonary embolism

127

2.52

5.59

1.1

1.2

—

Pain (limb, back, neck, head abdominally)

206

1.87

5.58

1.1

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

385

1.84

5.57

1.2

1.1

—

Any reimbursement code in KELA

140

2.08

5.56

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

110

2.64

5.54

1.1

1.2

—

Specific development disorders of speech and language

5.31

5.51

1.4

1.3

—

Pulmonary heart disease

128

2.50

5.51

1.1

1.2

—

Sequelae of infectious and parasitic diseases

4.50

5.51

1.4

1.2

—

Other disorders of glucose regulation and pancreatic internal secretion

4.50

5.50

1.2

1.3

—

Gastro-oesophageal reflux disease

355

1.82

5.49

1.2

1.1

—

Dorsopathies

108

329

1.68

5.46

1.1

—

Substance abuse, excluding more controls

265

1.95

5.43

1.2

1.1

—

Brain glioblastoma

16.25

5.43

1.1

1.4

—

Persons encountering health services in other circumstances, wide

123

396

1.61

5.39

1.2

1.1

—

Diseases of external ear

161

2.30

5.32

1.2

—

Diabetes medication

103

376

1.67

5.31

1.1

—

All influenza (not pneumonia)

3.28

5.29

1.0

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

107

322

1.67

5.29

1.2

1.1

—

Anogenital herpesviral [herpes simplex] infection

5.02

5.26

1.3

1.1

—

Disorders of eyelid, lacrimal system and orbit

392

1.72

5.26

1.2

1.1

—

Cervical disc disorders

194

2.17

5.25

1.1

1.2

—

Type 1 diabetes, wide definition

102

2.65

5.21

1.1

—

Other arthritis (FG)

138

2.39

5.19

1.1

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

138

2.39

5.19

1.2

—

Other external causes of accidental injury

241

1.77

5.17

1.2

1.1

—

Hypothyroidism (congenital or acquired)

3.15

5.15

1.1

1.0

—

Gastrointestinal diseases

162

1.95

5.14

1.2

1.1

—

Codeine or tramadol medication

117

404

1.60

5.13

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

326

1.87

5.12

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.64

5.11

1.1

—

Pain in throat and chest

309

1.72

5.08

1.2

1.1

—

Retention of urine

148

2.23

5.07

1.2

—

Internal derangement of knee

190

2.15

5.06

1.3

1.1

—

Disturbances of skin sensation

134

2.39

5.03

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

3.28

5.02

1.1

1.2

—

Hypertensive diseases (excluding secondary)

164

1.99

5.01

1.1

—

Post-traumatic stress disorder

4.79

5.01

1.4

1.2

—

Disorders of choroid and retina

357

1.71

5.01

1.1

—

Inflammatory diseases of female pelvic organs

228

1.92

4.99

1.2

1.1

—

Special screening examination for infectious and parasitic diseases

2.79

4.99

1.2

1.1

—

Diabetes mellitus

102

371

1.64

4.98

1.1

—

Accidents

241

1.75

4.93

1.2

1.1

—

Unspecified fall

258

1.96

4.93

1.2

1.1

—

Heart failure, not strict

308

1.75

4.92

1.1

1.2

—

Benign neoplasm of meninges

3.67

4.92

1.1

1.2

—

Subjective visual disturbances

100

2.60

4.88

1.2

—

Triptan medication for migraine, min. 3 purchases

226

1.92

4.82

1.2

1.1

—

Diabetes, varying definitions

101

371

1.63

4.79

1.1

—

Papilloedema, unspecified

11.52

4.79

1.1

1.6

—

Myalgia

107

2.53

4.78

1.1

1.2

—

Dental caries

112

2.48

4.76

1.1

1.2

—

313

1.82

4.73

1.2

1.1

—

Other abnormal uterine and vaginal bleeding

2.50

4.65

1.2

1.1

—

Hypothyroidism and >3 levothyroxin purchases

3.02

4.63

1.1

1.0

—

Hypothyroidism, levothyroxine purchases

3.02

4.63

1.1

1.0

—

Other specified/unspecified arthritis

127

2.37

4.63

1.0

1.2

—

Use of anticholinesterases

111

2.34

4.61

1.1

—

N06DA Anticholinesterases

111

2.34

4.61

1.1

—

Diseases of oesophagus, stomach and duodenum

108

415

1.58

4.60

1.2

1.1

—

Deviated nasal septum

179

2.12

4.56

1.2

1.1

—

Hypoglycaemia, other or unspecified

4.41

4.56

1.2

1.3

—

Renal failure

212

1.98

4.55

1.1

1.2

—

SLE (Finngen)

10.05

4.52

1.1

1.6

—

Abdominal and pelvic pain

100

311

1.62

4.48

1.1

—

Migraine without aura and triptan purchases

2.86

4.48

1.1

—

Abnormal findings on diagnostic imaging of lung

242

1.93

4.46

1.1

1.2

—

Enterocolitis due to Clostridium difficile

3.27

4.46

1.0

1.2

—

Injury, poisoning and certain other consequences of external causes

146

1.92

4.46

1.2

—

Superficial injury of head

2.53

4.45

1.1

1.2

—

Other disorders of nervous system

4.01

4.43

1.2

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

250

1.92

4.40

1.2

1.1

—

Diseases of the musculoskeletal system and connective tissue

147

1.91

4.39

1.1

1.2

—

Type 2 diabetes

359

1.60

4.39

1.1

—

Insulin, fast-acting (human)

3.01

4.39

1.2

—

Other functional intestinal disorders

238

1.92

4.38

1.1

—

Superficial injury of lower leg

106

2.46

4.36

1.2

1.1

—

Alcohol use disorder, Swedish definition

299

1.80

4.33

1.2

1.1

—

Injuries to the knee and lower leg

116

433

1.53

4.31

1.2

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.56

4.30

1.1

1.2

—

Diseases of the skin and subcutaneous tissue

101

318

1.59

4.29

1.2

1.1

—

Benign neoplasm: Cerebral meninges

3.88

4.25

1.0

1.3

—

Other retinal disorders

294

1.75

4.24

1.1

—

323

1.75

4.23

1.2

1.1

—

Budesonide

3.04

4.23

1.2

—

Dermatitis and eczema

106

449

1.55

4.22

1.1

—

Open wound of head

257

1.88

4.22

1.2

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

293

1.67

4.22

1.2

1.1

—

Use of rivastigmine

3.04

4.21

1.1

1.2

—

Other diseases of intestines

104

387

1.56

4.21

1.1

—

DVT of lower extremities and pulmonary embolism

205

2.00

4.20

1.1

1.2

—

Pain in limb

318

1.68

4.20

1.2

—

Benign neoplasm of other and unspecified endocrine glands

3.14

4.20

1.2

1.3

—

severe traumatic brain injury, does not include concussion

2.50

4.20

1.0

1.2

—

Conjunctivitis (acute, non atopic)

133

2.25

4.17

1.1

—

Cutaneous abscess, furuncle and carbuncle

121

2.32

4.16

1.3

1.1

—

Diabetic nephropathy, excluding more controls

2.79

4.12

1.1

—

Abnormal involuntary movements

2.99

4.11

1.2

—

Allergic contact dermatitis

2.99

4.11

1.1

1.2

—

Other viral diseases, not elsewhere classified

2.59

4.10

1.2

1.1

—

Speech and linguistic disorders

4.07

4.09

1.4

1.2

—

Sub-endpoint used in defining T1D endpoints

145

2.17

4.09

1.1

—

Elevated blood glucose level

3.76

4.08

1.0

1.3

—

Polymyalgia rheumatica

3.08

4.08

1.1

1.2

—

Chronic lymphocytic leukaemia

8.06

4.06

1.1

1.3

—

Monoplegia

10.11

4.02

1.7

1.4

—

Paraplegia, diplegia of upper limbs

10.07

4.01

1.1

1.6

—

Diabetic retinopathy, strict definition

2.53

4.01

1.1

—

Striking against or struck by other objects

162

2.10

4.01

1.2

1.1

—

Disorders of lens

251

1.71

3.99

1.2

—

Temporal arteritis

6.47

3.98

1.2

1.3

—

Giant cell arteritis with polymyalgia rheumatica

6.47

3.98

1.2

1.3

—

Disorders of psychological development

3.33

3.95

1.3

1.2

—

Unspecified dementia

3.74

3.95

1.2

—

Soft tissue disorders

101

338

1.55

3.92

1.1

—

Other disorders of bladder

3.26

3.90

1.1

1.2

—

Other disorders of skin and subcutaneous tissue

367

1.67

3.90

1.1

—

Other specified/unspecified systemic involvement of connective tissue

4.18

3.89

1.1

1.3

—

Benign neoplasm of brain and other parts of central nervous system

4.18

3.88

1.2

1.3

—

Mental and behavioural disorders due to alcohol

290

1.78

3.87

1.2

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

7.32

3.86

1.1

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

7.32

3.86

1.1

1.3

—

Injuries to the thorax

241

1.87

3.85

1.1

—

Mood [affective] disorders

419

1.54

3.85

1.1

1.2

—

Genitourinary diseases

169

1.78

3.84

1.2

1.1

—

Spondylopathies

286

1.64

3.83

1.2

—

Factors influencing health status and contact with health services

2.29

3.83

1.3

1.1

—

Mood disorders

419

1.54

3.82

1.1

1.2

—

Mental and behavioural disorders due to psychoactive substance use

338

1.70

3.82

1.2

1.1

—

Giant cell arteritis

6.03

3.82

1.2

1.3

—

Arthropathies

289

1.59

3.81

1.2

1.1

—

Diabetic retinopathy, excluding more controls

2.24

3.78

1.1

—

Infections with a predominantly sexual mode of transmission

146

2.12

3.78

1.2

1.1

—

Complications of genitourinary prosthetic devices, implants and grafts

8.81

3.77

1.0

1.6

—

Presence of other functional implants

230

1.76

3.77

1.1

1.2

—

Hernia of abdominal wall, postoperative

3.19

3.77

1.1

1.2

—

Extrapyramidal and movement disorders

180

2.00

3.76

1.1

1.2

—

Heartburn

3.54

3.76

1.1

—

Unspecific neurodegenerative disorder

135

1.99

3.76

1.2

1.1

—

Non-follicular lymphoma, hilmo, excluding all cancers

3.34

3.76

1.1

1.2

—

Substance abuse

330

1.71

3.75

1.2

1.1

—

Inflammatory diseases of prostate (prostatitis)

2.73

3.75

1.2

—

Aneurysms, operations, SAH

2.73

3.74

1.1

1.2

—

Injuries to the shoulder and upper arm

423

1.59

3.74

1.1

—

Vocal cord dysfunction

3.36

3.72

1.2

1.1

—

Bronchitis

100

432

1.52

3.71

1.1

1.2

—

Other disorders of patella

2.57

3.71

1.2

—

Bacterial intestinal infections, IBD co-morbidities

2.57

3.71

1.1

1.2

—

Certain disorders involving the immune mechanism

2.45

3.70

1.3

1.1

—

Deposits [accretions] on teeth

4.03

3.69

1.3

—

Transient ischemic attack

219

1.82

3.67

1.2

1.1

—

Generalized skin eruption due to drugs and medicaments

5.65

3.66

1.3

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

5.65

3.66

1.1

1.3

—

Crohn disease

2.69

3.65

1.1

1.2

—

Generalized anxiety disorder

2.69

3.65

1.2

1.1

—

Diseases of liver

169

2.01

3.62

1.2

—

Care involving dialysis

3.44

3.61

1.2

1.3

—

Undefined dementia

3.45

3.57

1.2

1.3

—

Anaemia in chronic diseases classified elsewhere

7.83

3.56

1.1

1.4

—

Colonic or urogenital fistula

130

2.16

3.56

1.1

1.2

—

Chorioretinal inflammation

7.82

3.56

1.0

1.3

—

Disorder of external ear, unspecified

7.82

3.56

1.0

1.6

—

Other nutritional deficiencies

351

1.67

3.55

1.1

—

Other problems related to primary support group, including family circumstances

2.93

3.51

1.3

1.1

—

Open wound of wrist and hand

232

1.84

3.51

1.2

1.1

—

Hepatic failure, not elsewhere classified

6.18

3.50

1.4

—

Fungal Sepsis

6.18

3.50

1.0

1.2

—

Systemic lupus erythematosus

6.18

3.50

1.1

1.5

—

Other intracranial haemorrhages

10.04

3.50

1.2

1.7

—

Coxibs

2.17

3.50

1.2

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

353

1.54

3.49

1.1

—

Crohn's disease NAS

3.56

3.48

1.1

1.2

—

Other Crohn's disease

3.56

3.48

1.0

1.2

—

Pain associated with micturition

2.89

3.46

1.1

1.2

—

Other bacterial intestinal infections

2.54

3.45

1.1

1.2

—

Covid-19 suspected case

100

2.30

3.42

1.0

1.1

—

Misadventures to patients during surgical and medical care

2.76

3.41

1.3

1.2

—

Other disorders of eye and adnexa

2.66

3.39

1.2

1.1

—

Implicit fungal Sepsis

7.03

3.36

1.0

1.3

—

Early onset COPD, excluding more controls

2.50

3.36

1.2

1.1

—

Benign neoplasms

262

1.60

3.36

1.1

—

Benign neoplasm of brain and other parts of central nervous system

3.71

3.35

1.2

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.71

3.35

1.0

1.2

—

Crohn disease (strict definition, require KELA)

3.71

3.35

1.0

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.71

3.35

1.0

1.2

—

Alcohol use disorder, ICD-based

224

1.83

3.35

1.2

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

147

2.04

3.35

1.3

1.1

—

Selective serotonin reuptake inhibitors

314

1.53

3.34

1.2

1.1

—

Diseases of the ear and mastoid process

107

367

1.48

3.33

1.2

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

291

1.61

3.31

1.1

—

Triptan medication for migraine, single purchase ok

291

1.61

3.31

1.1

—

Other joint disorders

289

1.55

3.31

1.1

—

Dermatitis

344

1.66

3.30

1.2

1.1

—

Hypokalaemia

2.92

3.29

1.4

1.2

—

Other anxiety disorders

186

1.86

3.28

1.2

1.1

—

Lower back pain or/and sciatica

449

1.48

3.27

1.2

1.1

—

Myasthenia gravis

8.64

3.27

1.2

1.6

—

Non-follicular lymphoma

3.03

3.25

1.1

1.2

—

Abnormalities of breathing

321

1.54

3.24

1.2

1.1

—

Fracture of rib(s), sternum and thoracic spine

149

2.02

3.24

1.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

2.67

3.22

1.2

—

Disorders of mineral metabolism

3.17

3.21

1.1

1.2

—

Depression

403

1.50

3.21

1.1

1.2

—

Other CVD

2.44

3.20

1.1

1.2

—

Other dialysis

5.37

3.19

1.0

1.3

—

Sacroiliitis, not elsewhere classified

5.35

3.19

1.1

1.4

—

Explicit bacterial Sepsis

3.34

3.19

1.2

—

Other disorders of teeth and supporting structures

2.27

3.18

1.3

1.1

—

Other heart diseases, wide

368

1.50

3.16

1.1

1.2

—

Hypertension, essential

269

1.57

3.15

1.1

—

Other heart diseases

162

1.80

3.15

1.1

—

Injuries to the ankle and foot

352

1.61

3.14

1.2

1.1

—

Other (seronegative) rheumatoid arthritis, wide

2.36

3.14

1.1

1.2

—

Disorders of skin appendages

251

1.75

3.13

1.2

1.1

—

Problems related to lifestyle

2.96

3.13

1.5

1.1

—

Suicide or other Intentional self-harm

124

2.10

3.13

1.0

1.2

—

Migraine with aura and triptan purchases

2.54

3.12

1.2

1.1

—

Other blood glucose lowering drugs, excl. Insulins

2.54

3.12

1.4

1.2

—

Other symptoms and signs involving the digestive system and abdomen

2.54

3.12

1.1

—

Unspecified haematuria

189

1.81

3.11

1.1

1.2

—

Dialysis

4.52

3.11

1.0

1.3

—

Neoplasms

253

1.57

3.10

1.1

—

Senile cataract

232

1.63

3.09

1.2

—

Benign neoplasm: Cerebral meninges

3.08

3.09

1.0

1.2

—

Other shoulder lesions

3.08

1.0

1.2

—

Vitreous haemorrhage

2.81

3.08

1.0

1.2

—

Osteopathies and chondropathies

296

1.67

3.08

1.1

—

Alzheimer’s disease, wide definition, excluding more controls

3.78

3.08

1.2

1.0

—

Alzheimer disease, excluding more controls

3.50

3.05

1.3

1.0

—

Other sleep disorders

3.24

3.05

1.1

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

5.02

3.05

1.0

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

5.02

3.05

1.0

1.3

—

Fracture of skull and facial bones

2.22

3.05

1.1

—

Dementia in other diseases classified elsewhere

5.02

3.05

1.0

1.3

—

Tuberculosis, IBD comorbidity

3.46

3.04

1.0

1.3

—

Tuberculosis, wide

3.46

3.04

1.0

1.3

—

Streptococcal septicaemia

3.46

3.04

1.2

—

Postpartum care and examination

2.65

3.04

1.2

1.1

—

Gout, unspecified

2.26

3.02

1.0

1.2

—

Bacterial, viral and other infectious agents

2.90

3.02

1.0

1.2

—

Other intervertebral disc disorders

308

1.53

3.00

1.1

1.2

—

Anxiety (asthma-related co-morbidities)

246

1.67

3.00

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

189

1.85

2.98

1.1

—

Use of levodopa decarboxylase inhibitor

2.75

2.98

1.1

1.2

—

Other renal tubulo-interstitial diseases

10.04

2.98

1.2

1.6

—

Erysipelas

239

1.72

2.97

1.1

—

Other disorders of penis

3.01

2.97

1.0

1.2

—

All anxiety disorders

253

1.65

2.94

1.2

1.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

4.72

2.92

1.3

1.4

—

Seronegative rheumatoid arthritis

2.83

2.91

1.0

1.2

—

Rheumatoid arthritis, including avohilmo

191

1.83

2.91

1.1

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

380

1.47

2.90

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

142

1.97

2.89

1.1

—

Abnormal findings on diagnostic imaging of other body structures

2.70

2.88

1.1

1.2

—

Cardiac arrhythmias

207

1.66

2.88

1.0

1.1

—

Trigeminal neuralgia

4.10

2.88

1.0

1.2

—

SLE, ICD10

5.41

2.87

1.1

1.5

—

SLE, strict definition

5.41

2.87

1.1

1.5

—

KRA_PSY_EATING, excluding more controls

4.08

2.87

1.0

1.2

—

Nephropathy related operations

2.59

2.87

1.1

1.2

—

Family history of certain disabilities and chronic diseases leading to disablement

5.40

2.87

1.0

1.2

—

Hypotension

2.50

2.86

1.1

1.2

—

Hypothyroidism, drug reimbursement

3.28

2.86

1.3

1.0

—

Any dementia, excluding more controls

111

1.94

2.85

1.2

1.1

—

Diseases of the digestive system

236

1.73

2.84

1.1

1.2

—

Diabetic nephropathy

2.25

2.84

1.1

—

Asthma, excluding more controls

191

1.62

2.80

1.2

1.1

—

Diffuse large B-cell lymphoma

4.46

2.79

1.0

1.3

—

Monoarthritis, not elsewhere classified

4.46

2.79

1.3

1.2

—

Acute renal failure

2.23

2.79

1.1

1.2

—

Schizophrenia or delusion, excluding more controls

136

1.97

2.78

1.0

1.1

—

Pain in thoracic spine

2.55

2.78

1.1

1.2

—

Heart failure and antihypertensive medication

2.09

2.77

1.0

1.1

—

Recurrent or chronic depression

112

1.94

2.77

1.1

—

Other infectious diseases

3.23

2.77

1.2

—

Special screening examination for other diseases and disorders

3.92

2.77

1.0

1.1

—

Bipolar affective disorders

2.26

2.76

1.2

1.1

—

Other specified/unspecified necrotizing vasculopathies

8.40

2.75

1.2

1.3

—

Dyshidrosis [pompholyx]

8.39

2.75

1.2

1.8

—

Deficiency of other B group vitamins

8.38

2.75

1.0

1.7

—

Retinoschisis and retinal cysts

8.37

2.75

1.0

1.5

—

Covid-19 confirmed case

131

1.99

2.74

1.3

1.1

—

Gout, strict definition

2.31

2.74

1.1

1.2

—

Disorders of conjunctiva

402

1.50

2.73

1.2

1.1

—

Nonorganic sleeping disorders, excluding more controls

2.36

2.72

1.0

1.1

—

Other disorders of eyelid

232

1.71

2.70

1.2

1.1

—

Systemic lupus erythematosus, unspecified

6.03

2.70

1.2

1.5

—

Erosion and ectropion of cervix uteri

6.03

2.70

1.3

1.0

—

Parkinson's disease, strict definition

2.60

2.70

1.1

1.2

—

Temporomandibular joint disorders

2.60

2.70

1.1

—

Cardiac arrest

3.89

2.69

1.0

1.1

—

Constipation

384

1.47

2.69

1.2

1.1

—

Sicca syndrome [Sjögren]

2.98

2.69

1.1

1.2

—

Functional dyspepsia

139

1.94

2.69

1.0

1.1

—

Lymphoid leukaemia

4.22

2.68

1.1

1.4

—

Sequelae of other and unspecified infectious and parasitic diseases

3.76

2.67

1.6

1.2

—

Menorrhagia

101

1.86

2.67

1.1

—

Acute sinusitis

246

1.67

2.65

1.3

1.1

—

Hypertensive diseases

279

1.50

2.65

1.1

—

Conjunctivitis

366

1.52

2.64

1.2

1.1

—

Hypertension

279

1.50

2.64

1.1

—

Tonsillectomy and adenotomy

203

1.65

2.64

1.0

1.2

—

Rheumatoid arthritis

146

1.87

2.63

1.1

1.2

—

Degenerative diseases of the nervous system

109

1.94

2.62

1.2

1.1

—

Viral pneumonia

2.66

2.62

1.1

1.2

—

Dialysis, with operation codes

2.46

2.61

1.1

1.2

—

Chronic laryngitis and laryngotracheitis

2.46

2.61

1.3

1.1

—

Chronic periodontitis

2.46

2.61

1.1

1.2

—

Asthma, unspecified (mode), excluding more controls

177

1.73

2.61

1.3

1.1

—

Allergic asthma (mode), excluding more controls

2.32

2.61

1.1

—

Other diseases of the digestive system

162

1.85

2.60

1.1

1.2

—

IBD patients in KELA-register

120

2.00

2.60

1.1

—

Asthma (mode)

206

1.57

2.58

1.2

1.1

—

Volume depletion

2.90

2.58

1.1

1.2

—

Hyperlipidaemia, other/unspecified

188

1.76

2.58

1.2

—

Decubitus ulcer and pressure area

4.01

2.56

1.0

1.3

—

Convergent concomitant strabismus

4.01

2.56

1.1

1.3

—

Obstructive hydrocephalus

7.20

2.55

1.2

1.6

—

Benign neoplasm: Brain, supratentorial

7.19

2.55

1.0

1.6

—

Other and unspecified hydrocephalus

7.19

2.55

1.2

1.6

—

Tuberculosis of other organs, strict

7.17

2.55

1.0

1.3

—

Other obstetric conditions, not elsewhere classified

1.99

2.55

1.2

1.1

—

Carpal tunnel syndrome

304

1.57

2.55

1.2

1.1

—

Fissure and fistula of anal and rectal regions

121

1.99

2.54

1.1

1.2

—

Complications of other internal prosthetic devices, implants and grafts

5.47

2.54

1.3

1.5

—

Non-Hodgkin lymphoma, all

5.47

2.54

1.2

1.4

—

Other enthesopathies

142

1.90

2.54

1.3

1.1

—

Gout, FINNGEN

135

1.93

2.54

1.0

1.2

—

Irritable bowel syndrome

135

1.93

2.54

1.3

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

263

1.53

2.53

1.2

1.1

—

Gout

123

1.93

2.51

1.0

1.2

—

Diabetic neuropathy

2.41

2.50

1.1

—

Reimbursement for rheumatic diseases

323

1.58

2.50

1.1

—

Insomnia

2.27

2.50

1.0

1.2

—

Other and unspecified urticaria

2.16

2.50

1.3

1.1

—

Asthma

203

1.56

2.49

1.2

1.1

—

Other and unspecified visual disturbances

2.83

2.47

1.2

—

Asthma, unspecified (mode)

188

1.69

2.47

1.3

1.1

—

Atrial fibrillation and flutter with reimbursement

2.03

2.47

1.0

1.1

—

Chronic sinusitis

217

1.71

2.46

1.3

1.1

—

Hyperkalaemia

3.82

2.46

1.0

1.3

—

Other and unspecified injuries of head

3.82

2.46

1.3

1.1

—

Acute and transient psychotic disorders

2.38

2.46

1.1

1.2

—

Parkinson's disease

2.38

2.46

1.1

1.2

—

Maternal care for other conditions predominantly related to pregnancy

2.19

2.45

1.2

1.1

—

Polyuria

109

2.02

2.45

1.1

1.2

—

Gout, idiopatic and unspecified

123

1.95

2.44

1.0

1.2

—

Inflammatory bowel disease, strict (require KELA)

123

1.95

2.44

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

130

1.92

2.44

1.1

—

Familial hypercholesterolemia

2.24

2.43

1.3

1.2

—

Chronic diseases of tonsils and adenoids

294

1.49

2.43

1.1

—

Noninfective enteritis and colitis

256

1.64

2.42

1.1

1.2

—

Other (not insulin) diabetes medications

349

1.43

2.42

1.1

—

Gingivitis and periodontal diseases

293

1.45

2.42

1.1

1.2

—

Crohn's disease of small intestine

2.95

2.41

1.0

1.3

—

Other and unspecified effects of external causes

138

1.89

2.40

1.1

—

Diabetic retinopathy

121

1.78

2.40

1.1

—

Shoulder lesions

285

1.48

2.40

1.1

—

Type of accident

131

1.91

2.39

1.2

1.1

—

Hypopituitarism

3.34

2.39

1.2

1.3

—

Superficial injury of hip and thigh

2.35

2.38

1.1

1.2

—

Benign neoplasm: Brain, supratentorial

6.29

2.37

1.0

1.6

—

Other facial nerve disorders

6.27

2.37

1.0

1.5

—

Hidradenitis suppurativa

6.27

2.37

1.2

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

215

1.60

2.37

1.1

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.96

2.36

1.2

1.1

—

Calculus of lower urinary tract

3.65

2.36

1.0

1.2

—

Crohn disease (strict definition, all UC cases excluded)

3.65

2.36

1.0

1.3

—

Osteoporosis

112

1.96

2.35

1.0

1.1

—

Excessive attrition of teeth

120

1.72

2.34

1.0

1.2

—

Superficial injury of abdomen, lower back and pelvis

2.26

2.34

1.0

1.2

—

Any dementia

127

1.78

2.32

1.2

1.1

—

5-aminosalicylic acid

2.09

2.32

1.2

1.1

—

Hypothyroidism, strict autoimmune

258

1.51

2.31

1.2

1.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.22

2.30

1.0

1.3

—

Biguanides

361

1.42

2.30

1.1

—

Other diseases of hard tissues of teeth

280

1.52

2.30

1.1

1.2

—

Urticaria and erythema

192

1.72

2.28

1.2

1.1

—

Adrenocortical insufficiency

4.63

2.27

1.2

1.5

—

Chondrocostal junction syndrome [Tietze]

4.63

2.27

1.0

1.5

—

Cluster headache, strict, including avohilmo

3.49

2.27

1.1

1.3

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

3.49

2.27

1.3

—

Neuralgia and neuritis, unspecified

3.49

2.27

1.3

1.2

—

Crohn's disease of large intestine

3.49

2.27

1.1

1.3

—

Diseases of tongue

3.49

2.27

1.1

1.2

—

Abnormal spermatozoa

2.56

2.27

1.1

—

Thyroiditis, ILD-related definition

2.56

2.27

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.91

2.25

1.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

316

1.53

2.25

1.2

1.1

—

Other diseases of blood and blood-forming organs, wide

106

1.98

2.25

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

137

1.84

2.24

1.1

—

Parkinson's disease, including avohilmo

2.28

2.24

1.1

1.2

—

Benign neoplasm: Colon

199

1.62

2.24

1.1

1.2

—

Venous thromboembolism

293

1.56

2.22

1.1

—

Mixed connective tissue disease

3.11

2.22

1.1

1.3

—

Somatoform disorder

2.34

2.21

1.1

1.2

—

Angina pectoris

275

0.54

2.21

1.3

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

394

1.37

2.20

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

193

1.70

2.20

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

100

2.00

2.20

1.3

1.2

—

Diseases of oral cavity, salivary glands and jaws

293

1.42

2.20

1.1

1.2

—

Benign neoplasms

353

1.39

2.19

1.1

—

Diseases of peritoneum

2.50

2.18

1.0

1.2

—

Alzheimer’s disease (Late onset), excluding more controls

3.56

2.18

1.3

1.0

—

Tobacco use

3.34

2.18

1.5

1.3

—

Cluster headache, wide,, including avohilmo

3.34

2.18

1.1

1.3

—

Tuberculosis

3.34

2.18

1.0

1.3

—

Impingement syndrome of shoulder

129

1.86

2.16

1.3

1.2

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

127

1.79

2.16

1.0

1.2

—

Other disorders of amniotic fluid and membranes

2.39

2.15

1.2

1.1

—

Other disorders of adrenal gland

4.30

2.15

1.2

1.4

—

Varicella [chickenpox]

3.69

2.15

1.1

1.3

—

Residual foreign body in soft tissue

3.69

2.15

1.1

1.3

—

Extracorporeal dialysis

3.01

2.14

1.1

1.2

—

Exposure to other and unspecified inanimate mechanical forces

3.01

2.14

1.0

1.2

—

Allergic asthma (mode)

2.11

2.14

1.1

—

Inflammatory bowel disease

166

1.75

2.14

1.1

—

Combinations of oral blood glucose lowering drugs

144

1.81

2.14

1.2

—

Persons encountering health services for specific procedures and health care

416

1.37

2.13

1.1

1.2

—

Septal defects

3.27

2.13

1.3

—

Other/unspecified dorsalgia

173

1.73

2.12

1.1

1.2

—

Disorders of sclera, cornea, iris and ciliary body

298

1.54

2.12

1.2

1.1

—

Leisure time condition

2.10

2.12

1.2

1.1

—

Use of donepezil

2.22

2.12

1.2

—

Benign neoplasm: Colon, unspecified

108

1.94

2.12

1.1

1.2

—

L04AD Calcineurin inhibitors

2.45

2.10

1.2

—

Unspecified misadventure during surgical and medical care

3.21

2.09

1.3

—

Lymphoid leukaemia

3.21

2.09

1.1

1.4

—

Ectropion of eyelid

5.01

2.07

1.2

1.1

—

Urticaria

153

1.77

2.07

1.2

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.08

2.06

1.0

1.1

—

2.32

2.04

1.3

1.1

—

Other diseases of upper respiratory tract

369

1.36

2.04

1.2

1.1

—

Other and unspecified dermatitis

277

1.55

2.04

1.2

1.1

—

Obesity and other hyperalimentation

338

1.49

2.03

1.1

—

Acute suppurative otitis media

123

1.82

2.02

1.1

—

Sequelae of injuries of head

3.08

2.01

1.0

1.3

—

Tongue abnormality

3.08

2.01

1.1

1.3

—

Keratitis

177

1.70

2.01

1.3

1.1

—

GI-bleeding

162

1.73

2.01

1.1

1.2

—

Transplanted organ and tissue status

2.64

2.00

1.2

—

Other disorders of bone

1.96

1.99

1.1

1.2

—

Other and unspecified nonorganic psychotic disorders

1.96

1.99

1.1

—

Non-selective monoamine reuptake inhibitors

172

1.69

1.99

1.2

—

Vascular dementia

3.39

1.98

1.4

—

Respiratory tuberculosis

3.34

1.96

1.0

1.3

—

Respiratory tuberculosis, confirmed and not-confirmed

3.34

1.96

1.0

1.3

—

Sequelae of external causes of morbidity and mortality

119

1.85

1.96

1.1

1.2

—

Dyspnoea

421

1.38

1.96

1.2

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.99

1.95

1.2

1.1

—

Fall on and from stairs and steps

134

1.79

1.94

1.1

1.2

—

Chronic hepatitis, not elsewhere classified

4.56

1.94

1.2

1.4

—

Cluster headache, strict

4.56

1.94

1.2

—

Personal history of malignant neoplasm

4.56

1.94

1.2

1.3

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

4.55

1.94

1.2

—

Disorders of the thyroid gland

386

1.37

1.94

1.1

—

Obesity

334

1.48

1.94

1.1

—

Other and unspecified mood [affective] disorders

2.97

1.93

1.1

1.2

—

Left bundle-branch block

2.73

1.93

1.1

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

339

1.38

1.93

1.1

—

Unspecified/other endometriosis

2.57

1.92

1.1

1.0

—

Follow-up examination after treatment for malignant neoplasms

2.57

1.92

1.0

1.2

—

Injuries to the wrist and hand

455

1.35

1.91

1.2

1.1

—

Malignant neoplasm of breast

184

1.57

1.91

1.0

1.1

—

Substance use, excluding alcohol

1.92

1.89

1.1

—

Preparatory care for dialysis

3.19

1.88

1.1

1.3

—

Immunodeficiencies

3.19

1.88

1.4

1.3

—

Intermittent heterotropia

3.19

1.88

1.1

1.2

—

389

1.33

1.87

1.2

1.1

—

Excessive, frequent and irregular menstruation

115

1.65

1.86

1.3

1.1

—

Disorders of calcium metabolism

2.86

1.86

1.1

1.3

—

Congenital malformations of cardiac septa

2.87

1.86

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

151

1.72

1.85

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

259

1.49

1.85

1.1

1.2

—

Unspecified privation

2.39

1.85

1.1

1.2

—

Nonorganic sleeping disorders

1.98

1.84

1.0

1.2

—

Methotrexate

2.21

1.84

1.3

1.2

—

Immunodeficiency with predominantly antibody defects

4.18

1.82

1.6

1.5

—

Secondary parkinsonism+Parkinsonism in other disease

4.18

1.82

1.0

1.3

—

Cluster headache, wide

4.18

1.82

1.2

—

Cerebral aneurysm, nonruptured

2.58

1.80

1.1

1.2

—

Foreign body entering into or through eye or natural orifice

2.58

1.80

1.1

1.2

—

Eating disorder

2.57

1.79

1.0

1.2

—

Other strabismus

1.91

1.78

1.3

1.1

—

Benign neoplasm: Colon, unspecified

116

1.81

1.78

1.1

1.2

—

Subarachnoid haemorrhage

2.44

1.75

1.0

1.2

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

144

1.59

1.74

1.0

1.2

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

144

1.59

1.74

1.0

1.2

—

Obsessive-compulsive disorder

3.34

1.74

1.2

—

Other diseases of liver

1.98

1.74

1.1

—

Corneal ulcer

1.98

1.74

1.3

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.04

1.74

1.1

1.2

—

Benign neoplasm of eye and adnexa

2.50

1.74

1.1

1.3

—

Schizophrenia, schizotypal and delusional disorders

170

1.65

1.73

1.1

—

Endometriosis ASRM stages 3,4

110

1.82

1.72

1.1

—

Other and unspecified psoriasis

2.67

1.72

1.3

—

Acne vulgaris

2.67

1.72

1.1

1.2

—

Secondary parkinsonism

3.86

1.71

1.0

1.3

—

Dissociative [conversion] disorders

3.85

1.71

1.0

1.3

—

Candidiasis

2.13

1.71

1.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

103

1.85

1.71

1.2

—

Infective dermatitis

2.29

1.70

1.0

1.2

—

Urolithiasis

171

1.64

1.69

1.1

1.2

—

Obesity due to excess calories

242

1.53

1.69

1.1

—

Medicines for HER+ breast cancer

174

1.62

1.69

1.0

1.1

—

Tinnitus

111

1.80

1.68

1.1

—

Poisoning by medicine

111

1.80

1.68

1.0

1.1

—

Endometriosis of ovary

1.95

1.68

1.1

—

Other/unspecified rheumatoid arthritis

2.18

1.67

1.1

1.2

—

Dental caries 3 and operation codes

301

1.35

1.66

1.1

—

Desensitization to allergens

3.16

1.66

1.5

1.3

—

Anorexia (incl.atypical)

3.16

1.66

1.0

1.3

—

Diseases of inner ear

310

1.45

1.65

1.2

1.1

—

Malignant neoplasm of breast, HER2-negative

183

1.53

1.65

1.0

1.1

—

Kidney transplant status

2.81

1.65

1.1

1.2

—

Benign neoplasm: Adrenal gland

2.80

1.65

1.1

1.2

—

Abnormal findings on antenatal screening of mother

2.80

1.65

1.1

1.2

—

Thyrotoxicosis, other and/or unspecified

1.89

1.64

1.2

1.1

—

Asthma (only as main-diagnosis), excluding more controls

191

1.47

1.63

1.1

—

Endometriosis

105

1.64

1.63

1.1

—

Chronic periodontitis, complicated

2.25

1.63

1.1

1.2

—

Burns and corrosions of external body surface, specified by site

2.25

1.63

1.1

1.2

—

Other diseases of pleura

230

1.50

1.63

1.2

—

Ovarian cyst

111

1.62

1.63

1.0

1.1

—

Dental operations

198

1.43

1.62

1.2

1.1

—

Sequelae of injuries of neck and trunk

3.58

1.61

1.0

1.3

—

Spinal instabilities

3.58

1.61

1.0

1.4

—

Right bundle-branch block

3.58

1.61

1.4

—

Other specified/unspecified dorsopathies

3.58

1.61

1.0

1.4

—

Benign neoplasm: Skin of ear and external auricular canal

3.58

1.61

1.6

1.5

—

Non-small cell lung cancer, squamous

3.58

1.61

1.2

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

3.58

1.61

1.2

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

381

1.33

1.60

1.1

—

Fentanyl

2.33

1.60

1.0

1.2

—

Eating disorders

2.33

1.59

1.0

1.2

—

Opening and dilatation of root channel of tooth

2.50

1.59

1.1

1.2

—

Invasive ventilation

2.50

1.59

1.0

1.2

—

Assault by bodily force

2.50

1.59

1.1

1.2

—

Acute alcohol intoxication, ICD10

106

1.79

1.58

1.1

1.2

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

3.01

1.58

1.0

1.4

—

Hypermobility syndrome

3.00

1.58

1.0

1.3

—

Other follicular disorders

2.70

1.58

1.4

1.2

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.00

1.57

1.2

1.3

—

Retinal detachments and breaks

175

1.60

1.57

1.1

—

Abnormal findings on examination of blood, without diagnosis

246

1.48

1.56

1.1

1.2

—

Atopic dermatitis

252

1.46

1.55

1.1

—

Postpartum haemorrhage

1.82

1.54

1.1

—

Peripheral artery operations in Hilmo

2.11

1.54

1.1

1.2

—

Noninfectious colitis NAS

2.03

1.54

1.0

1.2

—

Burns and corrosions

2.03

1.54

1.1

1.2

—

Pleural effusion

2.03

1.54

1.2

—

Benign neoplasm: Stomach

2.43

1.53

1.3

—

Other peripheral vertigo

2.28

1.53

1.2

—

Malignant neoplasm of breast, HER-positive

166

1.60

1.53

1.0

1.2

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

328

1.33

1.53

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

328

1.33

1.53

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

328

1.33

1.53

1.1

1.2

—

Personality disorders, excluding more controls

100

1.80

1.52

1.1

1.2

—

Haemangioma, any site

0.00

1.52

0.0

1.2

—

Acute peritonitis

2.60

1.51

1.0

1.3

—

Reactive arthropathies, FINNGEN

2.60

1.51

1.0

1.2

—

Symptoms and signs concerning food and fluid intake

2.59

1.51

1.0

1.2

—

Non-invasive ventilation

1.96

1.50

1.5

1.1

—

DVT of lower extremities

1.86

1.50

1.1

1.2

—

Viral and other specified intestinal infections

1.83

1.50

1.1

—

Haemangioma and lymphangioma, any site

0.00

1.49

0.0

1.2

—

Acute upper respiratory infections

415

1.30

1.49

1.2

1.1

—

Cough

216

1.51

1.49

1.3

1.1

—

Type 2 diabetes, definitions combined

343

1.32

1.49

1.1

—

Disorders of parathyroid gland

1.86

1.49

1.0

1.2

—

Lateral epicondylitis

2.07

1.49

1.1

1.2

—

Hypothyroidism, other/unspecified

358

1.33

1.48

1.1

—

Nail disorders

2.44

1.47

1.4

1.2

—

Dental pulpitis 4

385

1.28

1.46

1.1

—

Smoking dependency

2.37

1.45

1.2

—

Acute alcohol intoxication

132

1.67

1.45

1.1

—

Schizophrenia or delusion

171

1.58

1.45

1.0

1.1

—

Viral pneumonia (unknown virus, not influenza)

2.50

1.45

1.1

1.3

—

Diaphragmatic hernia

195

1.54

1.45

1.2

1.1

—

Sleep disorders

102

1.77

1.44

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

211

1.52

1.44

1.2

1.1

—

Disorders of vitreous body and globe

286

1.43

1.44

1.0

1.2

—

Benign neoplasm: Skin of ear and external auricular canal

3.13

1.44

1.6

1.3

—

Optic neuritis

3.13

1.44

1.2

1.3

—

Benign neoplasm: Choroid

2.73

1.43

1.2

1.3

—

Foreign body in alimentary tract

2.73

1.43

1.2

1.3

—

Convalescence

2.73

1.43

1.0

1.3

—

Autoimmune hyperthyroidism

2.73

1.43

1.0

1.2

—

Assault

2.04

1.43

1.4

1.1

—

Other diseases of lip and oral mucosa

1.97

1.43

1.2

—

Mental and behavioural disorders due to tobacco

2.31

1.43

1.2

—

Use of disulfiram, acamprosate or naltrexone

2.31

1.43

1.1

1.2

—

Undetermined asthma, excluding more controls

2.31

1.42

1.6

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.79

1.42

1.2

—

Type 2 diabetes, strict (exclude DM1)

346

1.31

1.42

1.1

—

Dental pulpitis 1

387

1.28

1.41

1.1

—

Asthma and allergy, excluding more controls

2.28

1.41

1.1

—

Atopic dermatitis, strict definition

138

1.63

1.41

1.1

—

Diseases of arteries, arterioles and capillaries

300

1.37

1.41

1.1

1.2

—

Diseases of middle ear and mastoid

254

1.42

1.40

1.0

1.1

—

Sulfonylureas

156

1.54

1.39

1.1

1.2

—

Disorders of vitreous body

281

1.43

1.39

1.0

1.2

—

Coronary revascularization (ANGIO or CABG)

220

0.60

1.39

1.3

1.2

—

Spondylopathies (FG)

2.08

1.38

1.3

1.2

—

Thyrotoxicosis

119

1.68

1.37

1.2

1.1

—

Cirrhosis of liver, NAS

2.61

1.37

1.0

1.2

—

Need for other prophylactic measures

2.61

1.36

1.2

1.3

—

Vulvovaginal ulceration/inflammation in other diseases

2.61

1.36

1.0

1.3

—

Amputation

2.20

1.36

1.1

1.3

—

Chronic conjunctivitis

2.95

1.36

1.6

1.4

—

Separation of retinal layers (serosa)

2.95

1.36

1.2

—

Other noninflammatory disorders of cervix uteri

2.95

1.36

1.4

1.1

—

Hyperfunction of pituitary gland

2.95

1.36

2.4

1.3

—

Unknown and unspecified causes of morbidity

2.94

1.36

1.2

—

Injuries to the hip and thigh

226

1.46

1.35

1.2

1.1

—

Early onset COPD

112

1.70

1.35

1.2

—

Antepartum haemorrhage, not elsewhere classified

0.00

1.34

0.0

1.1

—

Calculus of kidney and ureter

151

1.59

1.34

1.1

1.2

—

Other noninflammatory disorders of uterus, except cervix

1.76

1.34

1.3

1.1

—

Schizoaffective disorder

0.00

1.33

0.0

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

2.13

1.33

1.5

1.2

—

Deep endometriosis

2.15

1.33

1.1

1.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.91

1.33

1.2

1.1

—

Dental caries 2 and operation codes

351

1.34

1.32

1.2

1.1

—

Asthma (only as main-diagnosis)

203

1.40

1.32

1.1

—

Asthma and allergy

2.12

1.31

1.1

—

Acute bronchitis

212

1.48

1.31

1.0

1.1

—

Spondylosis

256

1.41

1.31

1.0

1.2

—

Chondropathies

1.81

1.31

1.1

1.2

—

Haemorrhoids and perianal venous thrombosis

152

1.58

1.31

1.1

1.2

—

Other diseases of jaws

2.50

1.30

1.5

1.3

—

Hypermetropia

2.50

1.30

1.3

—

Other diseases of arteries and capillaries

2.10

1.30

1.1

1.3

—

Benign neoplasm: Skin of other and unspecified parts of face

2.10

1.30

1.0

1.2

—

Undetermined asthma

2.09

1.30

1.6

1.1

—

Fenamates

1.89

1.29

1.2

—

Use of hypnotics and sedatives

417

1.26

1.29

1.1

1.2

—

Radiculopathy

1.84

1.29

1.0

1.2

—

Suppurative and unspecified otitis media

163

1.52

1.29

1.1

—

Eustachian salpingitis and obstruction

2.36

1.29

1.0

1.2

—

Spontaneous rupture of synovium and tendon

2.36

1.29

1.4

1.2

—

Infectious mononucleosis

2.36

1.29

1.0

1.2

—

Disorders of vestibular function (Vertigo)

257

1.43

1.28

1.1

—

Irregular menses

182

1.47

1.28

1.2

1.1

—

Adverse effects, not elsewhere classified

1.76

1.28

1.1

—

Other and unspecified disorders of white blood cells

2.78

1.28

1.0

1.3

—

Systemic atrophies primarily affecting the central nervous system

2.78

1.28

1.4

1.3

—

Other and unspecified abdominal hernia

2.78

1.28

1.0

1.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

2.78

1.28

1.2

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

2.78

1.28

1.2

1.4

—

Noise effects on inner ear

2.78

1.28

1.6

1.2

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.78

1.28

1.2

—

Other diseases of peritoneum

2.78

1.28

1.0

1.4

—

Benign neoplasm of urinary organs

2.78

1.28

1.0

1.4

—

COPD (mode)

108

1.62

1.28

1.2

1.1

—

Ptosis of eyelid

2.09

1.27

1.2

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1.94

1.27

1.1

1.3

—

Superficial injury of shoulder and upper arm

2.05

1.26

1.2

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

2.05

1.26

1.3

1.2

—

Dental caries 1 and operation codes

289

1.30

1.25

1.2

1.1

—

Benign neoplasm: Colon

296

1.39

1.25

1.1

1.2

—

Spinal stenosis

229

1.40

1.25

1.2

—

Biological medication for rheuma

1.82

1.25

1.1

1.2

—

Fracture of shoulder and upper arm

170

1.53

1.25

1.2

1.1

—

Spondyloarthritis

1.82

1.25

1.2

—

Other diseases of anus and rectum

146

1.57

1.25

1.2

—

Other cataract

194

1.44

1.25

1.1

—

Dental operations, only avohilmo

222

1.34

1.24

1.2

1.1

—

Suppurative and necrotic conditions of lower respiratory tract

2.40

1.24

1.0

1.3

—

Other disorders of white blood cells

2.40

1.24

1.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS